Valuation Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-10 pm EDT			5-day change	1st Jan Change
485.39 ^USD	-2.24%		-8.08%	+7.07%

Jul. 09	RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $577 From $570	MT
Jul. 08	Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	123,195	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	7.1%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	109,559	104,729	99,755
Change	-	31.13%	47.8%	4.23%	11.09%	1.05%	-4.41%	-4.75%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	27.8x	24.8x	21x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	5.6x	4.66x	3.92x
PEG	-	0.5x	3.51x	2x	-0x	2x	2.1x	1.2x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	9.44x	8.61x	7.74x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	8.39x	7.32x	6.26x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	18.9x	15.7x	13.1x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	19.8x	16.7x	13.6x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	22.6x	20.6x	17.9x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	4.43%	4.86%	5.59%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	17.49	19.59	23.11
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,055	14,313	15,926
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	5,784	6,659	7,631
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,537	6,271	7,312
Net income ¹	2,342	3,322	3,620	-535.6	3,953	4,496	5,063	6,008
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-13,635	-18,465	-23,440
Reference price ²	219.60	288.78	406.89	402.70	453.36	485.39	485.39	485.39
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,805	-	-
Announcement Date	1/26/22	2/7/23	2/5/24	2/10/25	2/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	27.75x	8.39x	18.94x	-.--%	123B
ELI LILLY AND COMPANY	34.92x	12.63x	25.81x	0.57%	1,060B
JOHNSON & JOHNSON	27.42x	6.3x	17.1x	2.08%	619B
ABBVIE INC.	30.1x	7.34x	15.02x	2.76%	438B
ROCHE HOLDING AG	17.98x	4.45x	11.01x	2.97%	333B
NOVARTIS AG	21.52x	5.52x	13.36x	2.86%	282B
ASTRAZENECA PLC	21.56x	4.53x	12.65x	1.94%	267B
NOVO NORDISK A/S	14.17x	5.3x	10.9x	3.52%	218B
AMGEN INC.	23.78x	6.31x	11.12x	2.78%	196B
GILEAD SCIENCES, INC.	-46.81x	5.6x	30.89x	2.5%	161B
Average	17.24x	6.64x	16.68x	2.2%	369.71B
Weighted average by Cap.	23.96x	7.86x	18.18x	1.93%